Ribose (Furanose)

Ribose (Furanose)

SCHEMBL338518

NC(=O)c1cccnc1.OC[C@H]1OC(O)[C@H](O)[C@@H]1O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.59
F3 P13726 1/20 0.59
SARM1 Q6SZW1 1/20 0.59
SIRT2 Q8IXJ6 1/20 0.59
SIRT6 Q8N6T7 1/20 0.59
SIRT1 Q96EB6 1/20 0.59
SIRT3 Q9NTG7 1/20 0.59
SIRT5 Q9NXA8 1/20 0.59
SIRT4 Q9Y6E7 1/20 0.59
MKNK1 Q9BUB5 2/20 0.46
MKNK2 Q9HBH9 2/20 0.46
THRB P10828 1/20 0.42
ALDH1A1 P00352 2/20 0.41
CHEK2 O96017 1/20 0.41
APP P05067 1/20 0.41
GAA P10253 1/20 0.41
HCAR3 P49019 1/20 0.41
HCAR2 Q8TDS4 1/20 0.41
HK1 P19367 2/20 0.41
HK2 P52789 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ribose (Furanose) SCHEMBL18185139 1.00 F7 (0.59) F7F3SARM1SIRT2SIRT6
Ribose (Furanose) SCHEMBL14321532 1.00 F7 (0.59) F7F3SARM1SIRT2SIRT6
Ribose (Furanose) SCHEMBL23111913 0.99 F7 (0.58) F7F3SARM1SIRT2SIRT6
Ribose (Furanose) SCHEMBL17315074 0.97 F7 (0.56) F7F3SARM1SIRT2SIRT6
Ribose (Furanose) SCHEMBL17315036 0.95 F7 (0.54) F7F3SARM1SIRT2SIRT6
Ribose (Furanose) SCHEMBL17315030 0.95 F7 (0.54) F7F3SARM1SIRT2SIRT6
Ribose (Furanose) SCHEMBL18280884 0.95 F7 (0.54) F7F3SARM1SIRT2SIRT6
Ribose (Furanose) SCHEMBL23610533 0.95 F7 (0.54) F7F3SARM1SIRT2SIRT6
Ribose (Furanose) SCHEMBL25392429 0.94 F7 (0.52) F7F3SARM1SIRT2SIRT6
Ribose (Furanose) SCHEMBL28731657 0.93 F7 (0.51) F7F3SARM1SIRT2SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6117 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122081219-A Cryopreservation resuscitation fluid for immune cells and resuscitation method 2026-05-26 CN claimed
WO-2026106529-A1 NADP+-PRECURSOR AS ANTIAGING SUPPLEMENT DR CHARLES AB (SE) 2026-05-21 WO claimed
WO-2026106725-A1 CHLOROPHYLL DERIVATIVES, CAROTENOID DERIVATIVES, AND DIETARY SUPPLEMENTS FOR HUMAN OCULAR HEALTH AND VISUAL PERFORMANCE RETINABIO, INC. (US) 2026-05-21 WO claimed
EP-4744667-A2 EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF The Queen's University Of Belfast (GB) 2026-05-20 EP claimed
EP-3808347-B1 SUBSTANCES FOR TREATMENT OF FATTY LIVER-RELATED CONDITIONS SCANDIBIO THERAPEUTICS AB (SE) 2026-05-20 EP claimed
CN-122056386-A Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof 大连医诺生物股份有限公司 2026-05-19 CN claimed
WO-2026100273-A1 METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE NTT株式会社 2026-05-15 WO claimed
CN-122030612-A Shear-resistant slow-release microcapsule powder and preparation method and application thereof 大连医诺生物股份有限公司 2026-05-15 CN claimed
CN-122012366-A Mitochondrial in-vitro activity maintaining agent, preparation method and application 山东省泉溪生物技术有限公司 2026-05-12 CN claimed
CN-122005817-A Spermidine composition for inhibiting hair follicle stem cell aging and promoting growth phase to enter and application 上海麦角硫因生物科技集团有限公司 2026-05-12 CN claimed
US-20060002914-A1 treating or preventing axonal degradation in neuropathic diseases in mammals; axonopathy; administering an agent (such as NAD, NADH) that increases sirtuin activity in diseased and/or injured neurons and supporting cells in an amount effective to decrease axonal degeneration NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-01-05 US claimed
EP-0988059-B1 HUMAN QUINONE REDUCTASE 2 CONJUGATES FOR ADEPT AND GDEPT ENZACTA R & D LTD (GB) 2005-12-07 EP claimed
US-20050267023-A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2005-12-01 US claimed
US-20050227327-A1 Nicotinamide riboside kinase compositions and methods for using the same NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-10-13 US claimed
WO-2005077091-A2 NICOTINAMIDE RIBOSIDE KINASE COMPOSITIONS AND METHODS FOR USING THE SAME TRUSTEES OF DARTMOUTH COLLEGE (US) 2005-08-25 WO claimed
US-6867231-B1 Therapeutic systems ENZACTA R & D LIMITED (GB) 2005-03-15 US claimed
EP-1468698-A2 HUMAN QUINONE REDUCTASE 2 CONJUGATES FOR ADEPT AND GDEPT ENZACTA R & D LIMITED (GB) 2004-10-20 EP claimed
US-20030086933-A1 Therapeutic systems ENZACTA R & D LIMITED 2003-05-08 US claimed
EP-0988059-A2 HUMAN QUINONE REDUCTASE 2 CONJUGATES FOR ADEPT AND GDEPT ENZACTA R & D LIMITED (GB) 2000-03-29 EP claimed
WO-1998057662-A2 THERAPEUTIC SYSTEMS ENZACTA R & D LIMITED (GB) 1998-12-23 WO claimed